Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View
2011

Using Biomarkers to Predict Cancer Risk

publication Evidence: moderate

Author Information

Author(s): Li Xiaohong, Blount Patricia L., Vaughan Thomas L., Reid Brian J.

Primary Institution: University of Washington

Hypothesis

Can dynamic clonal evolution improve cancer risk prediction and early detection?

Conclusion

The study proposes a framework for using biomarkers in cancer risk management that accounts for the dynamic nature of cancer evolution.

Supporting Evidence

  • Early detection of cancer can significantly reduce mortality.
  • Current cancer screening models have limited success in reducing cancer mortality.
  • No molecular biomarkers have yet been validated as robust predictors of cancer progression.

Takeaway

This study looks at how we can use special markers in our bodies to better predict and find cancer early, which can help save lives.

Methodology

The study defines cancer risk prediction and early detection using simple physical models and evaluates the implications of dynamic clonal evolution.

Potential Biases

The study acknowledges potential biases in biomarker research due to inadequate study designs and complexity of biospecimens.

Limitations

Current biomarkers are imperfect and do not meet the conditions for perfect cancer risk prediction.

Digital Object Identifier (DOI)

10.1371/journal.pcbi.1001087

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication